MedPath

A Randomized Trial of NSAID Dosing Strategies

Phase 4
Completed
Conditions
Acute Pain
Musculoskeletal Pain
Interventions
Registration Number
NCT05239767
Lead Sponsor
Montefiore Medical Center
Brief Summary

This study will compare the efficacy of two different non-steroidal anti-inflammatory drugs (NSAIDs) ketorolac and ibuprofen for people with acute moderate or severe musculoskeletal pain. The investigators will also determine whether taking acetaminophen prior to the NSAID impacts efficacy

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
407
Inclusion Criteria
  • Acute musculoskeletal pain: Any pain attributable to muscles, bones, joints, tendons, ligaments or supporting structures, as determined by the clinical team, of 10 days duration or less. Prior to the onset of acute pain, patients cannot have experienced pain in the same body region during the prior six months
  • Pain has to be described as moderate or severe, when the patient is asked if the pain is mild, moderate or severe in intensity
Exclusion Criteria
  • Contraindication to NSAIDs (allergy to NSAID or allergy to aspirin without history of tolerating NSAIDs, history of gastrointestinal bleeding, daily medication for gastritis or PUD, chronic kidney disease 2-5, heart failure)
  • Contraindication to acetaminophen (hepatitis or cirrhosis)
  • Use of an NSAID within the previous eight hours
  • Use of acetaminophen within the previous eight hours
  • Chronic pain, defined as any pain on >50% of days for at least 3 months prior to onset of acute pain
  • Recurrent pain in the same body part as the presenting complaint

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
KetorolacNSAIDKetorolac 20mg orally x 1
IbuprofenNSAIDIbuprofen 800mg orally x 1
Primary Outcome Measures
NameTimeMethod
Failure to achieve a minimum clinically important differenceTwo hours

Failure to improve by at least 1.3 points on a 0-10 pain scale

Secondary Outcome Measures
NameTimeMethod
Epigastric painTwo hours after medication administration

Participants will be asked if the medication caused "stomach pain". Response options are "no", "a little", "a lot"

0-10 pain scoreOne and two hours after medication administration

Improvement on 0-10 pain

Ordinal pain scaleOne and two hours after medication administration

The investigators will determine the frequency of obtaining pain levels of "mild" and "none" on a scale of "severe", "moderate', "mild", or "none"

Trial Locations

Locations (1)

Montefiore

🇺🇸

Bronx, New York, United States

© Copyright 2025. All Rights Reserved by MedPath